Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

Por Mouriaux, F, Servois, V, Parienti, J J, Lesimple, T, Thyss, A, Dutriaux, C, Neidhart-Berard, E M, Penel, N, Delcambre, C, Peyro Saint Paul, L, Pham, A D, Heutte, N, Piperno-Neumann, S, Joly, F
Publicado no Br J Cancer (2016)

First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma

Por Le Tourneau, C, Dreno, B, Kirova, Y, Grob, J J, Jouary, T, Dutriaux, C, Thomas, L, Lebbé, C, Mortier, L, Saiag, P, Avril, M F, Maubec, E, Joly, P, Bey, P, Cosset, J M, Sun, J S, Asselain, B, Devun, F, Marty, M E, Dutreix, M
Publicado no Br J Cancer (2016)